Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor

BLOOD

AMER SOC HEMATOLOGY

1. National Institutes of Health, National Cancer Institute (NCI Leukemia Specialized Programs of Research Excellence) [P50 CA100632]